HealthCor Management L.P. purchased a new stake in MEDNAX Inc (NYSE:MD) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,261,620 shares of the company’s stock, valued at approximately $67,421,000. MEDNAX accounts for approximately 2.2% of HealthCor Management L.P.’s portfolio, making the stock its 22nd biggest position. HealthCor Management L.P. owned approximately 1.35% of MEDNAX as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Prudential Financial Inc. increased its position in shares of MEDNAX by 976.9% during the third quarter. Prudential Financial Inc. now owns 641,057 shares of the company’s stock worth $27,642,000 after buying an additional 581,527 shares during the period. Quantbot Technologies LP acquired a new stake in shares of MEDNAX during the third quarter worth $695,000. Point72 Asset Management L.P. boosted its stake in MEDNAX by 71.7% during the third quarter. Point72 Asset Management L.P. now owns 132,700 shares of the company’s stock worth $5,722,000 after acquiring an additional 55,400 shares in the last quarter. Advisor Group Inc. boosted its stake in MEDNAX by 41.9% during the third quarter. Advisor Group Inc. now owns 8,361 shares of the company’s stock worth $359,000 after acquiring an additional 2,468 shares in the last quarter. Finally, FDx Advisors Inc. boosted its stake in MEDNAX by 10.5% during the fourth quarter. FDx Advisors Inc. now owns 15,304 shares of the company’s stock worth $818,000 after acquiring an additional 1,450 shares in the last quarter. Hedge funds and other institutional investors own 98.53% of the company’s stock.
In other MEDNAX news, insider John C. Pepia sold 3,000 shares of the firm’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $51.58, for a total value of $154,740.00. Following the transaction, the insider now directly owns 35,569 shares of the company’s stock, valued at $1,834,649.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.40% of the stock is currently owned by company insiders.
MEDNAX Inc (NYSE MD) opened at $57.58 on Monday. MEDNAX Inc has a 12 month low of $40.56 and a 12 month high of $71.26. The firm has a market cap of $5,400.75, a price-to-earnings ratio of 18.34, a price-to-earnings-growth ratio of 1.43 and a beta of 0.26. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60.
MEDNAX (NYSE:MD) last released its quarterly earnings data on Thursday, February 8th. The company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.04. MEDNAX had a net margin of 9.26% and a return on equity of 10.10%. The firm had revenue of $910.82 million for the quarter, compared to analyst estimates of $884.55 million. During the same period last year, the firm earned $1.00 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. equities research analysts anticipate that MEDNAX Inc will post 4.03 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This piece was reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/12/1261620-shares-in-mednax-inc-md-acquired-by-healthcor-management-l-p.html.
MEDNAX Company Profile
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.